These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 16092938)

  • 1. Chronic hyperammonemia in vivo impairs long-term potentiation in hippocampus by altering activation of cyclic GMP-dependent-protein kinase and of phosphodiesterase 5.
    Monfort P; Muñoz MD; Felipo V
    J Neurochem; 2005 Aug; 94(4):934-42. PubMed ID: 16092938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential activation of soluble guanylate cyclase, protein kinase G and cGMP-degrading phosphodiesterase is necessary for proper induction of long-term potentiation in CA1 of hippocampus. Alterations in hyperammonemia.
    Monfort P; Muñoz MD; Kosenko E; Llansola M; Sánchez-Pérez A; Cauli O; Felipo V
    Neurochem Int; 2004 Nov; 45(6):895-901. PubMed ID: 15312984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperammonemia impairs long-term potentiation in hippocampus by altering the modulation of cGMP-degrading phosphodiesterase by protein kinase G.
    Monfort P; Muñoz MD; Felipo V
    Neurobiol Dis; 2004 Feb; 15(1):1-10. PubMed ID: 14751765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term potentiation in hippocampus involves sequential activation of soluble guanylate cyclase, cGMP-dependent protein kinase and cGMP-degrading phosphodiesterase, alterations in hyperammonemia.
    Monfort P; Felipo V
    BMC Pharmacol; 2005 Jun; 5 Suppl 1(Suppl 1):P66. PubMed ID: 15969770
    [No Abstract]   [Full Text] [Related]  

  • 5. Molecular mechanisms of the alterations in NMDA receptor-dependent long-term potentiation in hyperammonemia.
    Monfort P; Muñoz MD; Felipo V
    Metab Brain Dis; 2005 Dec; 20(4):265-74. PubMed ID: 16382337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term potentiation in hippocampus involves sequential activation of soluble guanylate cyclase, cGMP-dependent protein kinase, and cGMP-degrading phosphodiesterase.
    Monfort P; Muñoz MD; Kosenko E; Felipo V
    J Neurosci; 2002 Dec; 22(23):10116-22. PubMed ID: 12451112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclic GMP-dependent protein kinase activation and induction by exisulind and CP461 in colon tumor cells.
    Liu L; Li H; Underwood T; Lloyd M; David M; Sperl G; Pamukcu R; Thompson WJ
    J Pharmacol Exp Ther; 2001 Nov; 299(2):583-92. PubMed ID: 11602670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of guanylyl cyclase and cGMP-dependent protein kinase in long-term potentiation.
    Zhuo M; Hu Y; Schultz C; Kandel ER; Hawkins RD
    Nature; 1994 Apr; 368(6472):635-9. PubMed ID: 7908417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of long-term depression by increases in [guanosine 3',5'-cyclic monophosphate] in the hippocampal CA1 region of freely behaving rats.
    Stricker S; Manahan-Vaughan D
    Neuroscience; 2009 Jan; 158(1):159-66. PubMed ID: 18472342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloid-β impairs, and ibuprofen restores, the cGMP pathway, synaptic expression of AMPA receptors and long-term potentiation in the hippocampus.
    Monfort P; Felipo V
    J Alzheimers Dis; 2010; 22(3):795-809. PubMed ID: 20858955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of extracellular cGMP and of hyperammonemia in the impairment of learning in rats with chronic hepatic failure. Therapeutic implications.
    Erceg S; Monfort P; Cauli O; Montoliu C; Llansola M; Piedrafita B; Felipo V
    Neurochem Int; 2006; 48(6-7):441-6. PubMed ID: 16497413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired effect of salt loading on nitric oxide-mediated relaxation in aortas from stroke-prone spontaneously hypertensive rats.
    Kagota S; Kubota Y; Nejime N; Nakamura K; Kunitomo M; Shinozuka K
    Clin Exp Pharmacol Physiol; 2007; 34(1-2):48-54. PubMed ID: 17201735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interruption of homologous desensitization in cyclic guanosine 3',5'-monophosphate signaling restores colon cancer cytostasis by bacterial enterotoxins.
    Pitari GM; Baksh RI; Harris DM; Li P; Kazerounian S; Waldman SA
    Cancer Res; 2005 Dec; 65(23):11129-35. PubMed ID: 16322263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restoration of learning ability in hyperammonemic rats by increasing extracellular cGMP in brain.
    Erceg S; Monfort P; Hernandez-Viadel M; Llansola M; Montoliu C; Felipo V
    Brain Res; 2005 Mar; 1036(1-2):115-21. PubMed ID: 15725408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A critical role of NO/cGMP/PKG dependent pathway in hippocampal post-ischemic LTP: modulation by zonisamide.
    Costa C; Tozzi A; Siliquini S; Galletti F; Cardaioli G; Tantucci M; Pisani F; Calabresi P
    Neurobiol Dis; 2011 Nov; 44(2):185-91. PubMed ID: 21749921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic hyperammonemia reduces the activity of neuronal nitric oxide synthase in cerebellum by altering its localization and increasing its phosphorylation by calcium-calmodulin kinase II.
    El-Mlili N; Rodrigo R; Naghizadeh B; Cauli O; Felipo V
    J Neurochem; 2008 Aug; 106(3):1440-9. PubMed ID: 18498443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of cognitive alterations in hyperammonemia and hepatic encephalopathy: therapeutical implications.
    Monfort P; Cauli O; Montoliu C; Rodrigo R; Llansola M; Piedrafita B; El Mlili N; Boix J; Agustí A; Felipo V
    Neurochem Int; 2009; 55(1-3):106-12. PubMed ID: 19428813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperammonemia inhibits the natriuretic peptide receptor 2 (NPR-2)-mediated cyclic GMP synthesis in the astrocytic compartment of rat cerebral cortex slices.
    Zielińska M; Fresko I; Konopacka A; Felipo V; Albrecht J
    Neurotoxicology; 2007 Nov; 28(6):1260-3. PubMed ID: 17629948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclic GMP and phosphodiesterase 5 inhibitor therapies: what's on the horizon?
    Lincoln TM
    Mol Pharmacol; 2004 Jul; 66(1):11-3. PubMed ID: 15213291
    [No Abstract]   [Full Text] [Related]  

  • 20. Taurine rescues hippocampal long-term potentiation from ammonia-induced impairment.
    Chepkova AN; Sergeeva OA; Haas HL
    Neurobiol Dis; 2006 Sep; 23(3):512-21. PubMed ID: 16766203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.